Ibutilide
Antiarrhythmic — CARDIOVASCULAR SYSTEM
Also known as: ibutilide fumarate, U 82209E, U-82209E, U82209E
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ibutilide is an ofp drug in the Antiarrhythmic class catalogued in DrugCentral. It was first approved by the FDA in 1995. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.
- Approval status: ofp (first approved 1995 by the FDA).
- Drug class: Antiarrhythmic.
- Molecular targets: KCNH2 (1 listed in DrugCentral).
- Indications: Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.
- ATC code: C01BD05 (Antiarrhythmics, class III).
- Molecular formula: C20H36N2O3S; molecular weight 384.59 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Cardioversion of Atrial Fibrillation
- Cardioversion of Atrial Flutter
Contraindications (7)
- Bradycardia
- Congenital long QT syndrome
- Heart block
- Hypokalemia
- Hypomagnesemia
- Prolonged QT interval
- Torsades de pointes
Mechanism & targets
| Established pharmacologic class | Antiarrhythmic |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | blocker | IC50 8.00 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1995-12-28 | FDA | — | PHARMACIA AND UPJOHN |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01BD05 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › ANTIARRHYTHMICS, CLASS I AND III › Antiarrhythmics, class III |
Chemical structure
| Molecular formula | C20H36N2O3S |
|---|---|
| Molecular weight | 384.59 g/mol |
| CAS number | — |
| InChIKey | ALOBUEHUHMBRLE-UHFFFAOYSA-N |
| PubChem CID | 60753 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Ibutilide used for?
DrugCentral lists the following indications for Ibutilide: Cardioversion of Atrial Fibrillation and Cardioversion of Atrial Flutter.
How does Ibutilide work?
Its molecular targets in DrugCentral include KCNH2 (blocker).
When was Ibutilide first approved?
Ibutilide was first approved by the FDA in 1995.
What drug class does Ibutilide belong to?
Ibutilide is in the Antiarrhythmic class.
What is the chemical formula of Ibutilide?
Ibutilide has the molecular formula C20H36N2O3S and a molecular weight of 384.59 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1412 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2355456 — compound record and bioactivity
- PubChem CID 60753 — chemical identifiers
- DrugBank DB00308 — drug record
- FDA UNII 2436VX1U9B — substance identity
- DailyMed: FDA labels for Ibutilide — current prescribing information (label search)
- UniProt Q12809 (KCNH2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.